Cammarata S - Search Results

1

Possible influence of a non-synonymous polymorphism located in the NGF precursor on susceptibility to late-onset Alzheimer's disease and mild cognitive impairment.

Di Maria E, Giorgio E, Uliana V, Bonvicini C, Faravelli F, Cammarata S, Novello MC, Galimberti D, Scarpini E, Zanetti O, Gennarelli M, Tabaton M. Di Maria E, et al. Among authors: cammarata s. J Alzheimers Dis. 2012;29(3):699-705. doi: 10.3233/JAD-2012-112006. J Alzheimers Dis. 2012. PMID: 22330829 Free article.

2

Balance features in Alzheimer's disease and amnestic mild cognitive impairment.

Leandri M, Cammisuli S, Cammarata S, Baratto L, Campbell J, Simonini M, Tabaton M. Leandri M, et al. Among authors: cammarata s. J Alzheimers Dis. 2009;16(1):113-20. doi: 10.3233/JAD-2009-0928. J Alzheimers Dis. 2009. PMID: 19158427

3

The H1 haplotype of the tau gene (MAPT) is associated with mild cognitive impairment.

Di Maria E, Cammarata S, Parodi MI, Borghi R, Benussi L, Galli M, Galimberti D, Ghidoni R, Gonella D, Novello C, Pollero V, Perroni L, Odetti P, Scarpini E, Binetti G, Tabaton M. Di Maria E, et al. Among authors: cammarata s. J Alzheimers Dis. 2010;19(3):909-14. doi: 10.3233/JAD-2010-1285. J Alzheimers Dis. 2010. PMID: 20157246

4

Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters.

Monacelli F, Borghi R, Cammarata S, Nencioni A, Piccini A, Tabaton M, Odetti P. Monacelli F, et al. Among authors: cammarata s. J Alzheimers Dis. 2015;45(1):89-95. doi: 10.3233/JAD-142511. J Alzheimers Dis. 2015. PMID: 25471189

5

Plasma levels of insulin and amyloid beta 42 are correlated in patients with amnestic Mild Cognitive Impairment.

Odetti P, Piccini A, Giliberto L, Borghi R, Natale A, Monacelli F, Marchese M, Assini A, Colucci M, Cammarata S, Tabaton M. Odetti P, et al. Among authors: cammarata s. J Alzheimers Dis. 2005 Dec;8(3):243-5. doi: 10.3233/jad-2005-8303. J Alzheimers Dis. 2005. PMID: 16340082

6

Amyloid-beta42 plasma levels are elevated in amnestic mild cognitive impairment.

Cammarata S, Borghi R, Giliberto L, Pardini M, Pollero V, Novello C, Fornaro M, Vitali A, Bracco L, Caltagirone C, Bossù P, Odetti P, Tabaton M. Cammarata S, et al. J Alzheimers Dis. 2009;18(2):267-71. doi: 10.3233/JAD-2009-1144. J Alzheimers Dis. 2009. PMID: 19584444

7

Artificial neural networks identify the predictive values of risk factors on the conversion of amnestic mild cognitive impairment.

Tabaton M, Odetti P, Cammarata S, Borghi R, Monacelli F, Caltagirone C, Bossù P, Buscema M, Grossi E. Tabaton M, et al. Among authors: cammarata s. J Alzheimers Dis. 2010;19(3):1035-40. doi: 10.3233/JAD-2010-1300. J Alzheimers Dis. 2010. PMID: 20157257

8

Survival rate in patients affected by dementia followed by memory clinics (UVA) in Italy.

Ientile L, De Pasquale R, Monacelli F, Odetti P, Traverso N, Cammarata S, Tabaton M, Dijk B. Ientile L, et al. Among authors: cammarata s. J Alzheimers Dis. 2013;36(2):303-9. doi: 10.3233/JAD-130002. J Alzheimers Dis. 2013. PMID: 23609761

9

Ubiquitin-reactive axons have a widespread distribution and are unrelated to prion protein plaques in Creutzfeldt-Jakob disease.

Cammarata S, Tabaton M. Cammarata S, et al. J Neurol Sci. 1992 Jul;110(1-2):32-6. doi: 10.1016/0022-510x(92)90006-7. J Neurol Sci. 1992. PMID: 1354719

10

Formic acid treatment exposes hidden neurofilament and tau epitopes in abnormal cytoskeletal filaments from patients with progressive supranuclear palsy and Alzheimer's disease.

Cammarata S, Mancardi G, Tabaton M. Cammarata S, et al. Neurosci Lett. 1990 Jul 31;115(2-3):351-5. doi: 10.1016/0304-3940(90)90481-n. Neurosci Lett. 1990. PMID: 1700345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page